PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 22, 2026BJU International4 citations

Area deprivation and cancer‐specific mortality in non‐muscle‐invasive bladder cancer: a statewide analysis

View Full Paper
CSCarlo SilvaniHenry Ford Health SystemASAlfonso SantangeloHenry Ford Health SystemJCJack ConsidineHenry Ford Health System

Key Points

  • The aim was to assess the relationship between neighborhood socioeconomic deprivation and cancer-specific mortality in non-muscle-invasive bladder cancer patients.
  • Retrospective review of non-muscle-invasive bladder cancer patients from the Michigan Cancer Surveillance Program (2004–2019)
  • Socioeconomic deprivation measured using the Area Deprivation Index (ADI) and stratified into quartiles
  • Cumulative incidence functions compared cancer-specific mortality across ADI quartiles
  • Competing-risk regression analyzed the association between ADI and cancer-specific mortality after adjusting for covariates
  • Cumulative incidence of cancer-specific mortality was 7.3%, 7.9%, 8.7%, and 9.7% across the first to fourth ADI quartiles respectively (P = 0.002)
  • Each 25-point increase in ADI was linked to a 6% higher hazard of cancer-specific mortality (95% CI 1.01–1.12; P = 0.032)
  • Older age, higher T stage, unmarried status, and Medicaid insurance were associated with greater cancer-specific mortality.

Abstract

Objectives To evaluate whether neighbourhood socioeconomic deprivation, measured by the Area Deprivation Index (ADI), is associated with cancer‐specific mortality (CSM) in patients with non‐muscle‐invasive bladder cancer (NMIBC). Patients and Methods We retrospectively reviewed patients with NMIBC (T stage <2, node‐negative, non‐metastatic) from Michigan Cancer Surveillance Program (2004–2019). ADI national percentiles were assigned based on residential census block groups and stratified into quartiles, with the fourth quartile (ADI 75–100) being the most deprived. Cumulative incidence functions compared CSM between quartiles, and competing‐risk regression analysis assessed the association between ADI and CSM after adjusting for covariates. Results Among 19 722 patients (92.2% non‐Hispanic White; median interquartile range age 72 64–80 years; 76.7% male), most resided in metropolitan areas (81%) and 61% were married. Overall, 8.5%, 26.4%, 34.9%, and 30.2% of patients were in the first, second, third, and fourth ADI quartile, respectively. At 10 years, the cumulative incidence of CSM was 7.3%, 7.9%, 8.7%, and 9.7% across the first–fourth quartiles, respectively ( P = 0.002). At the competing risk analysis, each 25‐point increase in ADI was associated with a 6% higher hazard of CSM (95% confidence interval 1.01–1.12; P = 0.032). Older age, higher T stage, unmarried status, and Medicaid insurance were independently associated with greater CSM. Conclusions Higher ADI was associated with increased CSM in our cohort. Evaluating socioeconomic context in NMIBC care may inform follow‐up and therapy and, potentially, influence progression and mortality.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Silvani et al. (2026) studied this question.

synapsesocial.com/papers/6971bfdff17b5dc6da021f3ahttps://doi.org/10.1111/bju.70151
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Socioeconomic disparities and bladder cancer stage at diagnosis: a statewide cohort analysis2025 · 7 citations
  2. 2Race/Ethnicity, Gender, and Monitoring Socioeconomic Gradients in Health: A Comparison of Area-Based Socioeconomic Measures—The Public Health Disparities Geocoding Project2003 · 720 citations
  3. 3Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Implications for Clinical Trial Design. Reply.2021 · 1 citations
  4. 4Estimated Costs and Long-term Outcomes of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer Treated With Bacillus Calmette-Guérin in the Veterans Affairs Health System2021 · 64 citations
  5. 5The potential and limitations of data from population-based state cancer registries2000 · 133 citations